Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 3 Interventional

PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen

ClinicalTrials.gov ID: NCT00088660

Public ClinicalTrials.gov record NCT00088660. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 11:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomized, Controlled Study to Evaluate the Safety and Efficacy of PANVAC™-VF in Combination With GM-CSF Versus Best Supportive Care or Palliative Chemotherapy in Patients With Metastatic (Stage IV) Adenocarcinoma of the Pancreas Who Have Failed a Gemcitabine-Containing Chemotherapy Regimen

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objectives of this multi-center, randomized, controlled trial are to evaluate the safety and efficacy of PANVAC-VF in combination with Granulocyte-macrophage colony-stimulating factor (GM-CSF) versus best supportive care or palliative chemotherapy.

Study identification

NCT ID
NCT00088660
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Therion Biologics Corporation
Industry
Enrollment
250 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2004 (Type not available)
Primary completion
Not listed
Completion
Not listed
Last update posted
Feb 8, 2006

Started 2004

United States locations

U.S. sites
62
U.S. states
31
U.S. cities
55
Facility City State ZIP Site status
University of South Alabama/ Cancer Research Institute Mobile Alabama 36693 —
Moores UCSD Cancer Center La Jolla California 92093 —
Pacific Shores Medical Group Long Beach California 90813 —
USC/Norris Comprehensive Cancer Center Los Angeles California 90033 —
Chao Family Comprehensice Cancer Center Orange California 92868 —
Desert Hematology Oncology Medical Group, Inc Rancho Mirage California 92270 —
Scripps Cancer Center San Diego California 92121 —
VA San Diego Healthcare System San Diego California 92161 —
University of Colorado Health Science Center Aurora Colorado 80045 —
Greeley Medical Clinic Greeley Colorado 80631 —
Loveland Hematology Oncology Loveland Colorado 80538 —
Norwalk Hospital/ Whittingham Cancer Center Norwalk Connecticut 06856 —
Lombardi Comprehensive Cancer Center Washington D.C. District of Columbia 20007 —
Washington Hospital Cancer Center Washington D.C. District of Columbia 20010 —
Jupiter Medical Center Jupiter Florida 33458 —
VA Medical Center Miami Florida 33125 —
Jackson Memorial Hospital Miami Florida 33136 —
Sylvester Cancer Center Miami Florida 33136 —
St. Luke's Mountain States Tumor Institute Boise Idaho 83712 —
North Idaho Cancer Center Coeur d'Alene Idaho 83814 —
Carle Cancer Center Urbana Illinois 61801 —
Oncology Associates Cedar Rapids Iowa 52403 —
University of Kentucky Lexington Kentucky 40536 —
Hematology Oncology Life Center Alexandria Louisiana 71301 —
Medical Oncology, LLC Baton Rouge Louisiana 70809 —
Jayne Gurtler, MD and Laura Brinz, MD APMC Metairie Louisiana 70006 —
Tulane Cancer Center New Orleans Louisiana 70112 —
Maine Center for Cancer Medicine and Blood Disorders Scarborough Maine 04074 —
Franklin Square Hospital Baltimore Maryland 21237 —
Tufts-New England Medical Center, The Neeley Center for Clinical Research Boston Massachusetts 02111 —
Josephine Ford Cancer Center Detroit Michigan 48202 —
Kansas City Cancer Center Kansas City Missouri 64111 —
Saint Louis University Cancer Center St Louis Missouri 63110 —
Washington University School of Medicine St Louis Missouri 63110 —
Great Falls Clinic, LLP Great Falls Montana 59405 —
Nebraska Methodist Hospital Omaha Nebraska 68114 —
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756 —
The Cancer Institute of New Jersey New Brunswick New Jersey 08901 —
New York Oncology Hematology Albany New York 12208 —
Winthrop Oncology/Hematology Division Mineola New York 11501 —
Columbia Presbyterian Medical Center New York New York 10032 —
Duke University Medical Center Durham North Carolina 27710 —
Gabrail Cancer Center Canton Ohio 44718 —
Hematology Oncology Consultants, Inc. Columbus Ohio 43235 —
Dayton Oncology Hematology Kettering Ohio 45409 —
University of Oklahoma Health Science Center Oklahoma City Oklahoma 73104 —
Temple University Cancer Center Philadelphia Pennsylvania 19140 —
Charleston Hematology Oncology Charleston South Carolina 29403 —
Charleston Cancer Center Charleston South Carolina 29406 —
Cancer Centers of the Carolinas Greenville South Carolina 29605 —
The Sarah Cannon Cancer Center Nashville Tennessee 37203 —
Arlington Cancer Center Arlington Texas 76012 —
Mary Crowley Medical Research Center Dallas Texas 75246 —
Texas Cancer Care Fort Worth Texas 76104 —
Dr. H. Alejandro Preti, F.A.C.P. Houston Texas 77030 —
Elkins Pancreas Center Houston Texas 77030 —
Tyler Cancer Center Tyler Texas 75702 —
Texas Cancer Care Weatherford Texas 76086 —
Virginia Cancer Institute Richmond Virginia 23220 —
Swedish Cancer Institute Seattle Washington 98104 —
Cancer Care Northwest Spokane Washington 99218 —
Medical Consultants Ltd. Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00088660, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 8, 2006 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00088660 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →